Stage 1 Registered Report: sex differences in anticoagulation and stroke outcomes among patients with atrial fibrillation: a registry-based cohort study
Brain Communications · 31.10.2026 · 8 (6)
DOI: 10.1093/braincomms/fcag386 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Brain Communications, online erschienen am 22.10.2026. Verfasst von Benedikte L Nygaard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neuroscience Research Group, Stavanger University Hospital, 4068 Stavanger, Norway. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dam Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Women with atrial fibrillation have a higher risk of ischaemic stroke and worse functional outcomes than men but may be less likely to receive adequate anticoagulation. Preliminary single-centre findings in patients treated with endovascular thrombectomy for large vessel occlusion suggest that women may be under-anticoagulated prior to stroke onset. This Stage 1 Registered Report outlines a prespecified analysis plan to test sex-based differences in anticoagulation, stroke characteristics, treatment and outcomes in a prespecified confirmatory population and to explore whether similar patterns are observed at the national level. Using a retrospective cohort design, we will analyse local data from Stavanger University Hospital (2009–22) and national data from the Norwegian Stroke Registry. Confirmatory analyses will include patients with atrial fibrillation and large vessel occlusion treated with endovascular thrombectomy. Sex differences in anticoagulation, stroke severity, treatments and outcomes will be examined using chi-square tests and prespecified regression models; equivalence testing will be applied where appropriate. Exploratory analyses will assess age, comorbidity and healthcare delivery as potential mediators and moderators. No confirmatory analyses have been conducted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Neuroscience Research Group, Stavanger University Hospital, 4068 Stavanger, Norway.
- Faculty of Health Sciences, University of Stavanger, 4036 Stavanger, Norway.
- Division of Internal Medicine, Stavanger University Hospital, 4068 Stavanger, Norway.
- Stavanger Medical Imaging Laboratory (SMIL), Department of Radiology, Stavanger University Hospital, 4068 Stavanger, Norway.
- Department of Electrical and Computer Engineering, University of Stavanger, 4036 Stavanger, Norway.
- Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.
ORCID-Profile: Benedikte L Nygaard, Soffien C Ajmi, Camilla J H Normand, Lars Fjetland, Friedrich M W Kurz
Förderung
- Dam Foundation
Zitieren
APA
Nygaard, B. L., Ajmi, S. C., Normand, C. J. H., Kurz, K. D., Fjetland, L., & Kurz, F. M. W. (2026). Stage 1 Registered Report: sex differences in anticoagulation and stroke outcomes among patients with atrial fibrillation: a registry-based cohort study. Brain Communications, 8(6). https://doi.org/10.1093/braincomms/fcag386
Vancouver
Nygaard BL, Ajmi SC, Normand CJH, Kurz KD, Fjetland L, Kurz FMW. Stage 1 Registered Report: sex differences in anticoagulation and stroke outcomes among patients with atrial fibrillation: a registry-based cohort study. Brain Communications. 2026;8(6). doi:10.1093/braincomms/fcag386
BibTeX
@article{Nygaard2026,
author = {Nygaard, Benedikte L and Ajmi, Soffien C and Normand, Camilla J H and Kurz, Kathinka D and Fjetland, Lars and Kurz, Friedrich M W},
title = {Stage 1 Registered Report: sex differences in anticoagulation and stroke outcomes among patients with atrial fibrillation: a registry-based cohort study},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/braincomms/fcag386}
}
EUVIMED